STOK News and Press, Stoke Therapeutics Inc. From 03/26/24

2024-03-26 16:36:29 ET More on Stoke Therapeutics Stoke stock rockets 73% on updated epilepsy drug data TD Cowen ups Stoke to buy on updated data for epilepsy drug Seeking Alpha’s Quant Rating on Stoke Therapeutics Historical earnings data for Stoke Th...

A look at the top 10 most actives in the United States C3is Inc. (CISS) rose 36.6% to $0.0481 on volume of 589,492,515 shares Nikola Corporation (NKLA) rose 9.5% to $0.8139 on volume of 120,009,646 shares Tesla Inc. (TSLA) rose 2.9% to $177.67 on volume of 112,332,335 shares Direxion Da...

2024-03-26 12:55:48 ET More on Mid-day movers & stocks. Veritone: Not An AI Stock To Bank On Veritone, Inc. (VERI) Q4 2023 Earnings Call Transcript Check-Cap jumps on Nobul AI business combination Veritone Non-GAAP EPS of -$0.16 in-line, revenue of $34.2M...

Stoke Therapeutics, Inc. (NASDAQ: STOK) is one of today's top gainers. The company's shares have moved 59.23% on the day to $10.35. Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of sev...

2024-03-26 10:29:11 ET More on Stoke Therapeutics TD Cowen ups Stoke to buy on updated data for epilepsy drug Stoke stock soars 70% post-market on epilepsy drug data Seeking Alpha’s Quant Rating on Stoke Therapeutics Historical earnings data for Stoke ...

2024-03-26 10:01:57 ET More on Stoke Therapeutics Stoke stock soars 70% post-market on epilepsy drug data Seeking Alpha’s Quant Rating on Stoke Therapeutics Historical earnings data for Stoke Therapeutics Financial information for Stoke Therapeutics ...

A look at the top 10 most actives in the United States C3is Inc. (CISS) rose 50.9% to $0.0531 on volume of 188,520,681 shares OpGen Inc. (OPGN) rose 64.8% to $0.783 on volume of 46,448,042 shares KULR Technology Group Inc. (KULR) rose 26.2% to $0.4102 on volume of 30,163,025 shares Tesl...

2024-03-26 09:00:03 ET Joseph Stringer from Needham issued a price target of $22.00 for STOK on 2024-03-26 07:10:00. The adjusted price target was set to $22.00. At the time of the announcement, STOK was trading at $6.5. The overall price target consensus is at $41.50 wi...

2024-03-26 05:23:14 ET More on related stocks Westport Fuel Systems: Q4 Earnings Review And Update MicroStrategy: A Bad Deal For Investors MicroStrategy: Too Far, Too Fast Stoke stock soars 70% post-market on epilepsy drug data MicroStrategy buys 9,24...

2024-03-25 18:02:21 ET More on Stoke Therapeutics Stoke stock soars 70% post-market on epilepsy drug data Seeking Alpha’s Quant Rating on Stoke Therapeutics Historical earnings data for Stoke Therapeutics Read the full article on Seeking Alpha ...